Avalo Therapeutics, Inc. (AVTX): SCHEDULE 13G filed Feb 10, 2026

Form type

SCHEDULE 13G

Filing date

Feb 10, 2026

Accession number

0001104659-26-012459

Filer

Avalo Therapeutics, Inc. (CIK 1534120)